Patterns of fatigue during a course of chemotherapy: results from a multi-centre study

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Fatigue is a highly prevalent condition among patients with cancer affecting between 70% and 100% and patients describe their fatigue experiences as the most distressing of symptoms. However, the management of fatigue is complicated by our current lack of understanding of its pathophysiology. This study aimed to gain an insight into the longitudinal fatigue experiences of patients receiving chemotherapy. A convenience sample of patients receiving chemotherapy (n=249) were recruited and recorded their fatigue experiences using a paper questionnaire for 14 consecutive days following each cycle of chemotherapy. Fatigue was reported in 57% of all completed questionnaires. Patients report fatigue as a relatively constant presence following chemotherapy. Moreover, fatigue experiences increase over consecutive cycles of chemotherapy. This study supports the existing evidence illustrating fatigue as a significant problem for patients with cancer and provides new data demonstrating patterns of fatigue over the duration of a course of chemotherapy. Understanding this experience of fatigue should prompt health professionals providing care for this patient population to seek and test a range of management strategies to help patients maintain their quality of life during cancer treatment.

LanguageEnglish
Pages126-132
Number of pages7
JournalEuropean Journal of Oncology Nursing
Volume11
Issue number2
DOIs
Publication statusPublished - 30 Apr 2007
Externally publishedYes

Fingerprint

Fatigue
Drug Therapy
Neoplasms
Patient Care
Quality of Life
Health

Keywords

  • severity of illness index
  • antineoplastic agents
  • neoplasms

Cite this

@article{d5a317d4d7e340c3b4cdaab63e555640,
title = "Patterns of fatigue during a course of chemotherapy: results from a multi-centre study",
abstract = "Fatigue is a highly prevalent condition among patients with cancer affecting between 70{\%} and 100{\%} and patients describe their fatigue experiences as the most distressing of symptoms. However, the management of fatigue is complicated by our current lack of understanding of its pathophysiology. This study aimed to gain an insight into the longitudinal fatigue experiences of patients receiving chemotherapy. A convenience sample of patients receiving chemotherapy (n=249) were recruited and recorded their fatigue experiences using a paper questionnaire for 14 consecutive days following each cycle of chemotherapy. Fatigue was reported in 57{\%} of all completed questionnaires. Patients report fatigue as a relatively constant presence following chemotherapy. Moreover, fatigue experiences increase over consecutive cycles of chemotherapy. This study supports the existing evidence illustrating fatigue as a significant problem for patients with cancer and provides new data demonstrating patterns of fatigue over the duration of a course of chemotherapy. Understanding this experience of fatigue should prompt health professionals providing care for this patient population to seek and test a range of management strategies to help patients maintain their quality of life during cancer treatment.",
keywords = "severity of illness index, antineoplastic agents, neoplasms",
author = "Morven Miller and Roma Maguire and Nora Kearney",
year = "2007",
month = "4",
day = "30",
doi = "10.1016/j.ejon.2006.05.001",
language = "English",
volume = "11",
pages = "126--132",
journal = "European Journal of Oncology Nursing",
issn = "1462-3889",
number = "2",

}

Patterns of fatigue during a course of chemotherapy : results from a multi-centre study. / Miller, Morven; Maguire, Roma; Kearney, Nora.

In: European Journal of Oncology Nursing, Vol. 11, No. 2, 30.04.2007, p. 126-132.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Patterns of fatigue during a course of chemotherapy

T2 - European Journal of Oncology Nursing

AU - Miller, Morven

AU - Maguire, Roma

AU - Kearney, Nora

PY - 2007/4/30

Y1 - 2007/4/30

N2 - Fatigue is a highly prevalent condition among patients with cancer affecting between 70% and 100% and patients describe their fatigue experiences as the most distressing of symptoms. However, the management of fatigue is complicated by our current lack of understanding of its pathophysiology. This study aimed to gain an insight into the longitudinal fatigue experiences of patients receiving chemotherapy. A convenience sample of patients receiving chemotherapy (n=249) were recruited and recorded their fatigue experiences using a paper questionnaire for 14 consecutive days following each cycle of chemotherapy. Fatigue was reported in 57% of all completed questionnaires. Patients report fatigue as a relatively constant presence following chemotherapy. Moreover, fatigue experiences increase over consecutive cycles of chemotherapy. This study supports the existing evidence illustrating fatigue as a significant problem for patients with cancer and provides new data demonstrating patterns of fatigue over the duration of a course of chemotherapy. Understanding this experience of fatigue should prompt health professionals providing care for this patient population to seek and test a range of management strategies to help patients maintain their quality of life during cancer treatment.

AB - Fatigue is a highly prevalent condition among patients with cancer affecting between 70% and 100% and patients describe their fatigue experiences as the most distressing of symptoms. However, the management of fatigue is complicated by our current lack of understanding of its pathophysiology. This study aimed to gain an insight into the longitudinal fatigue experiences of patients receiving chemotherapy. A convenience sample of patients receiving chemotherapy (n=249) were recruited and recorded their fatigue experiences using a paper questionnaire for 14 consecutive days following each cycle of chemotherapy. Fatigue was reported in 57% of all completed questionnaires. Patients report fatigue as a relatively constant presence following chemotherapy. Moreover, fatigue experiences increase over consecutive cycles of chemotherapy. This study supports the existing evidence illustrating fatigue as a significant problem for patients with cancer and provides new data demonstrating patterns of fatigue over the duration of a course of chemotherapy. Understanding this experience of fatigue should prompt health professionals providing care for this patient population to seek and test a range of management strategies to help patients maintain their quality of life during cancer treatment.

KW - severity of illness index

KW - antineoplastic agents

KW - neoplasms

U2 - 10.1016/j.ejon.2006.05.001

DO - 10.1016/j.ejon.2006.05.001

M3 - Article

VL - 11

SP - 126

EP - 132

JO - European Journal of Oncology Nursing

JF - European Journal of Oncology Nursing

SN - 1462-3889

IS - 2

ER -